Rood's Approach and Oxaliplatin-induced Peripheral Neuropathy in Colorectal Cancer Patients
NCT ID: NCT05882396
Last Updated: 2023-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-06-01
2024-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rood's approach group
Thirty colorectal cancer patients have oxaliplatin-induced peripheral neuropathy.
Rood's approach
Patients will receive Rood's approach includes various facilitatory and inhibitory techniques.
Traditional physical therapy program
Participants will be engaged in aerobic exercises and balance training, three times per week for twelve weeks.
Traditional physical therapy program group
Thirty colorectal cancer patients have oxaliplatin-induced peripheral neuropathy.
Traditional physical therapy program
Participants will be engaged in aerobic exercises and balance training, three times per week for twelve weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rood's approach
Patients will receive Rood's approach includes various facilitatory and inhibitory techniques.
Traditional physical therapy program
Participants will be engaged in aerobic exercises and balance training, three times per week for twelve weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Colorectal cancer patients who have oxaliplatin-induced peripheral neuropathy, the patients included in the study with mild to moderate neuropathy according to mTNS.
* Patients from both genders.
* Their ages range from 18 to 60 years old.
Exclusion Criteria
* Patients with an unstable medical condition during chemotherapy.
* Patients who are starting new therapy or dose modification during the study period.
* Patients with morbid obesity "body mass index \>40%".
* Patients with a history of non-surgically repaired nerve compression injuries such as carpal tunnel, brachial plexopathy, spinal stenosis, and spinal nerve root compression.
* Patients with a history of central nervous system primary or metastatic malignancy.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Mohamed Ahmed Elsayeh
Lecturer of physical therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaimaa MA El Sayeh, PhD
Role: PRINCIPAL_INVESTIGATOR
Lecturer at Faculty of Physical Therapy, Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004322
Identifier Type: -
Identifier Source: org_study_id